ORGANIZATION

• Generic Use Rate at 56.1% in October-December 2015: JGA
  April 1, 2016

• JPMA Issues Notification Urging Member Companies to Strengthen Internal Ad Review Systems
  March 25, 2016

• FPMAJ Braced for Thorny Path Ahead Even If Sales Tax Postponed, Revenue Falls Would Weigh on Industry: Chief
  March 18, 2016

• Discuss Role of Drugs in Overall Social Security System: Full Interview with FPMAJ Pricing Affairs Chief
  March 18, 2016

• “Huge-Seller” Re-Pricing Eroding Predictability of Japanese System: FPMAJ’s Kamoya
  March 10, 2016

• PhRMA Japan Committee Sets Out Guiding Principles for MSLs
  February 26, 2016

• FY2016 Reimbursement Policy Reform “Tough” on Industry: JPMA
  February 19, 2016

• Top MHLW Bureaucrat Says 80% Generic Share “Achievable”
  February 16, 2016

• Former JMA Pres. Eitaka Tsuboi Dies at 86
  February 15, 2016

• EFPIA Japan Lays Out Basic Principles on MSL Activities
  February 4, 2016

• Japanese Pharma Market to Shrink 30% over 10 Years with Annual Revisions: New PhRMA Japan Chief
  January 22, 2016

• JPMA Expels Kaketsuken over GMP Violations, Cover-Up
  January 22, 2016

• PhRMA Japan Representative Ira Wolf Dies at 70
  January 19, 2016

• JPMA Head Hints “Free Pricing” Could Be an Option in System Overhaul
  January 18, 2016

• JPMA Unveils Pharma Industry Vision 2025
  January 18, 2016

• PhRMA Picks Amy Jackson as New Japan Representative
  January 15, 2016

• Mandatory Cancer Registration Gets Underway in Japan
  January 14, 2016

• JGA Takes Sincerely 50% Pricing Rule for First Generics, There’s Limitation to Data Collection: Chief
  January 13, 2016

• EFPIA Japan Chief Raps Huge Seller Re-Pricing, Says April Reform Will Chill the Market
  January 8, 2016

• April Drug Price Revision “Will Be a Hard One” for the Industry: Pharma Leader Nakayama
  January 7, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 49
• 50
• 51
• 52
• 53
• 54
• 55
• 56
• 57
• …
• Next ›
• 最終 »